In Liposomal Oncology Technology Platform, we have the know how to develop biobetter forms of existing molecules as new molecules.
The first Liposomal Oncology Drug that will be manufactured will be Liposomal Cisplatin (LIPOPLATINUM) in facility of ForDoz Pharmaceuticals. in New Jersey, USA.
The Liposomal Oncology Drugs that we plan to introduce over the years will be all patented as biobetter products like Liposomal Carboplatin, Liposomal Docetaxel etc.
Within 2 years time, we plan to bring Liposomal Oncology Drugs that will have Orphan Drug status for Small Cell Lung Cancer and possibly for Pediatric Lung Cancer.
The use of liposomal oncology drugs will revolutionize treatment protocols of cancer patients with the inclusion of Inhalation Chemotherapy to the standard treatment protocols.